Literature DB >> 16916610

BAFF, APRIL and human B cell disorders.

Stuart G Tangye1, Vanessa L Bryant, Amanda K Cuss, Kim L Good.   

Abstract

B cells require signals from multiple sources for their development from precursor cells, and differentiation into effector cells. BAFF has been identified as a critical regulator of B cell development and differentiation. Defects in the production of BAFF and/or expression of its receptors have been associated with a diverse array of human immunopathologies characterised by perturbed B cell function and behaviour, including autoimmunity, malignancy, and immunodeficiency. This review will discuss the role of BAFF in the pathogenesis of these human immune disorders. It will also highlight relevant differences between the function of BAFF in humans and mice and the impact of this on the therapeutic utility of BAFF antagonists in the treatment of different human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916610     DOI: 10.1016/j.smim.2006.04.004

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  64 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

2.  "B" for Bad, Beneficial, or Both? Lung Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease.

Authors:  Jeffrey L Curtis; Christine M Freeman; Gary B Huffnagle
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

3.  Elevation of serum B-cell activating factor levels during visceral leishmaniasis.

Authors:  Yasuyuki Goto; Satoko Omachi; Chizu Sanjoba; Yoshitsugu Matsumoto
Journal:  Am J Trop Med Hyg       Date:  2014-08-25       Impact factor: 2.345

4.  Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.

Authors:  Suresh Pallikkuth; Sudheesh Pilakka Kanthikeel; Sandra Y Silva; Margaret Fischl; Rajendra Pahwa; Savita Pahwa
Journal:  J Allergy Clin Immunol       Date:  2011-07-12       Impact factor: 10.793

5.  Reduced APRIL expression induces cellular senescence via a HSPG-dependent pathway.

Authors:  Weifeng Ding; Shaoqing Ju; Shengyang Jiang; Li Zhu; Yueguo Wang; Huimin Wang
Journal:  Pathol Oncol Res       Date:  2009-05-26       Impact factor: 3.201

Review 6.  [B-cell-targeted therapy in the treatment of autoimmune diseases].

Authors:  P Roll; H-P Tony
Journal:  Z Rheumatol       Date:  2009-05       Impact factor: 1.372

Review 7.  Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies.

Authors:  Sigurdur Y Kristinsson; Lynn R Goldin; Magnus Björkholm; Jill Koshiol; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-07-07       Impact factor: 9.941

Review 8.  Roles of TRAF molecules in B lymphocyte function.

Authors:  Ping Xie; Zachary J Kraus; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2008-05-21       Impact factor: 7.638

9.  Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity.

Authors:  Debra D Bloom; Sofiya Reshetylo; Cassandra Nytes; Claudia T Goodsett; Peiman Hematti
Journal:  J Immunother       Date:  2018-06       Impact factor: 4.456

10.  Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient.

Authors:  Ping Liu; Ines Santisteban; Lauri M Burroughs; Hans D Ochs; Troy R Torgerson; Michael S Hershfield; David J Rawlings; Andrew M Scharenberg
Journal:  Clin Immunol       Date:  2008-10-25       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.